These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 8136744)
21. Bone marrow transplantation for acute lymphocytic leukemia utilizing total body irradiation followed by high doses of cytosine arabinoside: lack of superiority over cyclophosphamide-containing conditioning regimens. Woods WG; Ramsay NK; Weisdorf DJ; Haake R; Vallera DA; Kim TH; Lasky L; Nesbit ME; Bostrom B; Uckun F Bone Marrow Transplant; 1990 Jul; 6(1):9-16. PubMed ID: 2202462 [TBL] [Abstract][Full Text] [Related]
22. ABMT for early isolated extramedullary relapse of childhood ALL. Rossetti F; Messina C; Miniero R; Busca A; Sotti G; Cesaro S; Zanesco L; Colleselli P; Scotti G [corrected to Sotti G] Bone Marrow Transplant; 1993 Jul; 12(1):37-41. PubMed ID: 8374535 [TBL] [Abstract][Full Text] [Related]
23. The TAM regimen prior to allogeneic and autologous bone marrow transplantation for high-risk acute lymphoblastic leukemias: a cooperative study of 62 patients. Cahn JY; Bordigoni P; Souillet G; Pico JL; Plouvier E; Reiffers J; Benz-Lemoine E; Bergerat JP; Lutz P; Colombat P Bone Marrow Transplant; 1991 Jan; 7(1):1-4. PubMed ID: 2043871 [TBL] [Abstract][Full Text] [Related]
24. Intensified conditioning regimen in bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. Kröger N; Krüger W; Wacker-Backhaus G; Hegewisch-Becker S; Stockschläder M; Fuchs N; Rüssmann B; Renges H; Dürken M; Bielack S; de Wit M; Schuch G; Bartels H; Braumann D; Kuse R; Kabisch H; Erttmann R; Zander AR Bone Marrow Transplant; 1998 Dec; 22(11):1029-33. PubMed ID: 9877263 [TBL] [Abstract][Full Text] [Related]
25. [Autologous bone marrow transplantation in children with acute leukemia or non-Hodgkin's lymphoma]. Emminger W; Hinterberger W; Emminger-Schmidmeier W; Peters C; Fink FM; Zoubek A; Haas OA; Höcker P; Hawliczek R; Knapp W Wien Med Wochenschr; 1991; 141(9-10):225-8. PubMed ID: 1683071 [TBL] [Abstract][Full Text] [Related]
26. [Autologous bone marrow transplantation in pediatric cancer]. Ohira M Gan To Kagaku Ryoho; 1990 Dec; 17(12):2299-306. PubMed ID: 2260867 [TBL] [Abstract][Full Text] [Related]
27. Melphalan-total body irradiation and autologous bone marrow transplantation for adult acute leukemia beyond first remission. Mehta J; Powles R; Singhal S; Horton C; Tait D; Treleaven J Bone Marrow Transplant; 1996 Jul; 18(1):119-23. PubMed ID: 8832004 [TBL] [Abstract][Full Text] [Related]
28. Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia. Shigematsu A; Kondo T; Yamamoto S; Sugita J; Onozawa M; Kahata K; Endo T; Shiratori S; Ota S; Obara M; Wakasa K; Takahata M; Takeda Y; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M Biol Blood Marrow Transplant; 2008 May; 14(5):568-75. PubMed ID: 18410899 [TBL] [Abstract][Full Text] [Related]
29. Autologous bone marrow transplantation for childhood acute lymphoblastic leukemia: a novel combined approach consisting of ex vivo marrow purging, modulation of multi-drug resistance, induction of autograft vs leukemia effect, and post-transplant immuno- and chemotherapy (PTIC). Houtenbos I; Bracho F; Davenport V; Slack R; van de Ven C; Suen Y; Killen R; Shen V; Cairo MS Bone Marrow Transplant; 2001 Jan; 27(2):145-53. PubMed ID: 11281383 [TBL] [Abstract][Full Text] [Related]
30. Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/Austrian Pediatric Bone Marrow Transplantation Group. Koscielniak E; Klingebiel TH; Peters C; Hermann J; Burdach ST; Bender-Götze C; Müller-Weihrich ST; Treuner J Bone Marrow Transplant; 1997 Feb; 19(3):227-31. PubMed ID: 9028550 [TBL] [Abstract][Full Text] [Related]
31. Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies. Long GD; Amylon MD; Stockerl-Goldstein KE; Negrin RS; Chao NJ; Hu WW; Nademanee AP; Snyder DS; Hoppe RT; Vora N; Wong R; Niland J; Reichardt VL; Forman SJ; Blume KG Biol Blood Marrow Transplant; 1997 Dec; 3(6):324-30. PubMed ID: 9502300 [TBL] [Abstract][Full Text] [Related]
32. Allogeneic matched T-cell-depleted bone marrow transplantation for acute leukemia patients. Aristei C; Aversa F; Raymondi C; Marsella AR; Panizza BM; Perrucci E; Piro F; Maranzano E; Lupattelli M; Martelli MF; Latini P Cancer J Sci Am; 1996; 2(6):330-4. PubMed ID: 9166553 [TBL] [Abstract][Full Text] [Related]
33. A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission. Marks DI; Forman SJ; Blume KG; Pérez WS; Weisdorf DJ; Keating A; Gale RP; Cairo MS; Copelan EA; Horan JT; Lazarus HM; Litzow MR; McCarthy PL; Schultz KR; Smith DD; Trigg ME; Zhang MJ; Horowitz MM Biol Blood Marrow Transplant; 2006 Apr; 12(4):438-53. PubMed ID: 16545728 [TBL] [Abstract][Full Text] [Related]
34. Autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in second remission - long-term follow-up. Vaidya SJ; Atra A; Bahl S; Pinkerton CR; Calvagna V; Horton C; Milan S; Shepherd V; Brain C; Treleaven J; Powles R; Tait D; Meller ST Bone Marrow Transplant; 2000 Mar; 25(6):599-603. PubMed ID: 10734293 [TBL] [Abstract][Full Text] [Related]
35. Can busulfan replace fractionated total body irradiation as conditioning regimen for allogeneic bone marrow transplantation in children with acute lymphoblastic leukemia. Wachowiak J; Bettoni C; Lange A; Malicki J; Kaczmarek-Kanold M; Głuszak B; Suchnicki K; Daszkiewicz P; Ebell W Acta Haematol Pol; 1995; 26(4):377-84. PubMed ID: 8571739 [TBL] [Abstract][Full Text] [Related]
36. Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia. Kröger N; Zabelina T; Sonnenberg S; Krüger W; Renges H; Stute N; Finkenstein F; Mayer U; Holstein K; Fiedler W; Colberg H; Sonnen R; Kuse R; Braumann D; Metzner B; del Valle F; Erttmann R; Kabisch H; Zander AR Bone Marrow Transplant; 2000 Oct; 26(7):711-6. PubMed ID: 11042650 [TBL] [Abstract][Full Text] [Related]
37. Feasibility and efficacy of maintenance chemotherapy following autologous bone marrow transplantation for first remission acute lymphoblastic leukaemia. Tiley C; Powles R; Treleaven J; Catovsky D; Milan S; Teo CP; Catalano J; Mehta J; Shields M; Gupta P Bone Marrow Transplant; 1993 Nov; 12(5):449-55. PubMed ID: 8298555 [TBL] [Abstract][Full Text] [Related]
38. [High dose chemoradiotherapy with autologous hemotopoietic stem cell transplantation for treatment of patients with advanced Hodgkin's lymphoma: a report of 11 cases]. Zhou SY; Shi YK; He XH; Han XH; Liu P; Yang JL; Zhou AP; Feng FY Ai Zheng; 2002 Apr; 21(4):405-8. PubMed ID: 12452021 [TBL] [Abstract][Full Text] [Related]
39. Autologous bone marrow transplantation with monoclonal antibody purged marrow for children with acute lymphoblastic leukemia in second remission. Spanish Working Party for BMT in Children. Maldonado MS; Díaz-Heredia C; Badell I; Muñoz A; Ortega JJ; Cubells J; Otheo E; Olive T; Canals C; Pérez-Oteyza J Bone Marrow Transplant; 1998 Dec; 22(11):1043-7. PubMed ID: 9877265 [TBL] [Abstract][Full Text] [Related]
40. High-dose chemotherapy with autologous hematopoietic progenitor cell transplantation in children with high-risk NHL and ALL-preliminary results. Gorczyńska E; Toporski J; Bogusławska-Jaworska J; Słociak M Bone Marrow Transplant; 1998 Dec; 22 Suppl 4():S107-9. PubMed ID: 9916652 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]